This is the authors' abstract. We don't add key points for this paper.
Parkinson's disease (PD) is a multisystem disorder with characteristics of a chronic inflammatory disease. To develop effective immunomodulatory interventions to combat PD, we need to think innovatively about the implications of orchestrated central and peripheral innate and adaptive immune responses that occur as the disease begins and progresses.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Harms et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: